Education
About Us
Working with TipRanks
Follow Us
Zabrowksi Dan Insider Profile
4 Followers
Zabrowksi Dan, Director at Apexigen, holds ― shares in Apexigen (Ticker: APGN), holds ― shares in Actuate Therapeutics, Inc. (Ticker: ACTU). Most recently, Zabrowksi Dan ― shares of Apexigen on ― for an estimated value of ―.
Zabrowksi Dan Apexigen (APGN)Director
Apexigen (APGN)
Director
Not Ranked
Zabrowksi Dan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Zabrowksi Dan does not currently own shares as a corporate insider.
A breakdown of Zabrowksi Dan's holdings
Insider Roles
Director
Roles that Zabrowksi Dan holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Zabrowksi Dan
Zabrowksi Dan's Trading History
Apexigen
―
―
―
―
Actuate Therapeutics, Inc.
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Zabrowksi Dan's performance on stock
You May Also Like
Zabrowksi Dan insider profile FAQ
What is the percentage of profitable transactions made by Zabrowksi Dan?
The percentage of profitable transactions made by Zabrowksi Dan is ―.
What is the average return per transaction made by Zabrowksi Dan?
The average return per transaction made by Zabrowksi Dan is ―.
What stocks does Zabrowksi Dan hold?
Zabrowksi Dan holds: APGN, ACTU stocks.
What was Zabrowksi Dan’s latest transaction?
Zabrowksi Dan latest transaction was an Uninformative Buy of ―.
What was Zabrowksi Dan's most profitable transaction?
Zabrowksi Dan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Zabrowksi Dan's role in Apexigen?
Zabrowksi Dan's role in Apexigen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.